Hung Sheng Tan - Concepedia

Author

Hung Sheng Tan

Yale University

Also Known As

Hung Sheng Tan, Hung Sheng William Tan

Publications

Citations

H-Index

Concepts

All Affiliations

Yale University University of Pittsburgh Yale Cancer Center Jackson Laboratory

About

Hung Sheng Tan is an author at Yale University specializing in autoimmunity, immunology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	165
2	Cell Biology	3	3	165
3	Immunology	3	3	165
4	Cellular Therapies	2	2	101
5	Marrow Transplantation	2	2	136

Hung Sheng Tan

Publications

490

Citations

H-Index

Page 1

	Year	Citations
Effector memory CD4+ T cells mediate graft-versus-leukemia without inducing graft-versus-host disease Hong Zheng, Catherine Matte-Martone, Hongmei Li, Blood	2007	180
Profound Depletion of Host Conventional Dendritic Cells, Plasmacytoid Dendritic Cells, and B Cells Does Not Prevent Graft-versus-Host Disease Induction Hongmei Li, Anthony J. Demetris, Jennifer M. McNiff, The Journal of Immunology Cell TherapyImmunologyPathologyCd4 T Cell ResponsesImmunotherapy	2012	72
Graft-versus-Host Disease Is Independent of Innate Signaling Pathways Triggered by Pathogens in Host Hematopoietic Cells Hongmei Li‐Byarlay, Catherine Matte-Martone, Hung Sheng Tan, The Journal of Immunology Adaptive Immune SystemInnate Immune SystemImmunologyImmune RegulationPathology	2010	64
Mechanisms of antigen presentation to T cells in murine graft-versus-host disease: cross-presentation and the appearance of cross-presentation Xiaojian Wang, Hongmei Li, Catherine Matte-Martone, Blood	2011	53
Memory T cells from minor histocompatibility antigen–vaccinated and virus-immune donors improve GVL and immune reconstitution Ning Li, Catherine Matte-Martone, Hong Zheng, Blood	2011	50
Langerhans cells are not required for graft-versus-host disease Hongmei Li, Daniel H. Kaplan, Catherine Matte-Martone, Blood	2010	42
Graft-versus-Leukemia (GVL) against Mouse Blast-Crisis Chronic Myelogenous Leukemia (BC-CML) and Chronic-Phase Chronic Myelogenous Leukemia (CP-CML): Shared Mechanisms of T Cell Killing, but Programmed Death Ligands Render CP-CML and Not BC-CML GVL Resistant Catherine Matte-Martone, Srividhya Venkatesan, Hung Sheng Tan, The Journal of Immunology Hematological MalignancyT Cell KillingCell TherapyBc-cml Gvl ResistantMixed-phenotype Acute Leukemia	2011	29

Page 1